Document is current

Any future updates will be listed below

4-Hydroxyphenyl Retinamide Preferentially Targets FLT3 Mutated Acute Myeloid Leukemia via ROS Induction and NF-κB Inhibition

Crossref DOI link: https://doi.org/10.1007/s11596-020-2259-0

Published Online: 2020-10-29

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark